Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 5/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 5/20 | 0.40 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.39 |
| ▸ | TACR3 | P29371 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | CTSG | P08311 | 1/20 | 0.37 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.37 |
| ▸ | CMA1 | P23946 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31373087 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TAS1R3TAS1R1PLA2G2CTACR3 | |
| SCHEMBL4313304 | 0.92 | TACR3 (0.41) | ALDH1A1TAS1R3TAS1R1TACR3CNR2 | |
| SCHEMBL18694713 | 0.83 | TAS1R3 (0.47) | ALDH1A1TAS1R3TAS1R1CYP1A2 | |
| SCHEMBL8975870 | 0.82 | TAS1R3 (0.38) | TAS1R3TAS1R1PLA2G2CTACR3 | |
| SCHEMBL4639171 | 0.81 | MLYCD (0.52) | ALDH1A1TAS1R3TAS1R1CNR2CYP1A2 | |
| SCHEMBL8975448 | 0.81 | TAS1R3 (0.37) | TAS1R3TAS1R1PLA2G2CTACR3 | |
| SCHEMBL8883577 | 0.80 | TAS1R3 (0.36) | TAS1R3TAS1R1TACR3CNR2 | |
| SCHEMBL418872 | 0.80 | NAAA (0.54) | ALDH1A1 | |
| SCHEMBL14823376 | 0.80 | NAAA (0.54) | ALDH1A1 | |
| SCHEMBL29850750 | 0.80 | NAAA (0.54) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7947837-B2 | dimeric and polymeric compounds based upon fused ring tetracarboxylic imides, used as electronic thin films on substrates; transistors | POLYERA CORPORATION (US) | 2011-05-24 | — | — | US | disclosed |
| US-20080167435-A1 | Organic semiconductor materials and methods of preparing and use thereof | USINVEST LLC | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167435-A1 | Organic semiconductor materials and methods of preparing and use thereof | PNN, NBAS, PIEZO1 | ALDH1A1 4173/4885TAS1R3 2836/4885TAS1R1 2907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.